• Home
  • WISAM 2018 Webinar Series

WISAM 2018 Webinar Series

  • June 20, 2018
  • October 17, 2018
  • UnityPoint Health-Meriter, 202 S Park St, Madison WI 53715


Registration is closed

Treatment of Substance Use Disorders in Primary Care Webinar Series

This complimentary, four-part webinar series, funded in part through a Wisconsin Medical Society Foundation grant, provides timely information and updates related to the treatment of substance use disorders. All presenters are local experts with a clear understanding of Wisconsin’s rural issues and barriers to care.

Viewing Options:

  1. Attend in person as the session is recorded. All recordings will take place at Meriter Hospital,  McConnell Hall, 124. S. Brooks St. Madison, WI 53715;
  2. Watch the webinar on-demand after the video link becomes available approximately one week following the recording. Links will be added below.

Part 1:  Suboxone 2.0: Beyond the Basics; Ritu Bhatnagar, MD and John Ewing, MD, presenters

Learning Objectives: Describe ways to talk non-judgmentally about adherence and sensitive issues related to buprenorphine; Develop strategies for ongoing management of patients on buprenorphine in the primary care setting.

Recording date: June 20, 2018

View Webinar | Complete Post-Test to claim CME

Part 2: Interpretation of Urine Drug Screen; David Galbis-Reig, MD, presenter

Learning Objectives: Discuss the history of drug testing and its introduction into clinical practice; Describe the different drug testing matrices and the potential advantages and disadvantages of each in clinical practice; Understand the basics of urine drug testing: What to test, how to test, and in what situations to perform a urine drug screen; Understand the limitations of urine drug testing; Understand how to interpret a positive urine immunoassay and when to obtain confirmatory tests.

Recording date: July 18, 2018

View Webinar | Complete Post-Test to claim CME

Part 3: Treatment of Stimulant Disorder; Mark Lim, MD, presenter

Learning Objectives: Discuss appropriate treatment strategies for patients with stimulant disorder; Understand the limitations of combination pharmacotherapies for the management of stimulant disorder. 

Recording Date: August 15, 2018

View Webinar | Complete Post-Test to claim CME

Part 4: Treatment of Alcohol Use and Opioid Use Disorder in Pregnancy, presented by Jacquelyn Adams, MD 

Learning Objectives: Describe opioid use disorder and alcohol use disorder in pregnancy; Understand risks of withdrawal in pregnancy; Discuss current treatment standards and possible new therapies specific to pregnancy.

Recording Date: October 17, 2018 (live presentation will take place in Classroom #9 at McConnell Hall, Meriter Hospital, 124 S. Brooks St, Madison)

Webinar Link will be loaded soon... please check back!

Target audience: Primary care providers in rural areas of Wisconsin who receive little support and education for evidence-based treatment of substance use disorders.

AMA Credit Designation Statement: The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The Wisconsin Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Contact WISAM
563 Carter Court, Suite B
Kimberly, WI 54136

Powered by Wild Apricot Membership Software